Literature DB >> 26892653

Familial skin cancer syndromes: Increased risk of nonmelanotic skin cancers and extracutaneous tumors.

Prajakta D Jaju1, Katherine J Ransohoff1, Jean Y Tang1, Kavita Y Sarin2.   

Abstract

Nonmelanoma skin cancers (NMSCs) represent the most common malignancies worldwide, with reported incidence rising each year. Both cutaneous squamous cell carcinoma (SCC) and basal cell carcinoma (BCC), as well as other NMSCs, represent complex diseases with a combination of environmental and genetic risk factors. In general, hereditary cancer syndromes that increase the risk of NMSC fall under several broad categories: those associated with immunodeficiencies, those that affect skin pigmentation, and those that perturb key molecular pathways involved in the pathogenesis of NMSCs. Many of the syndromes are also associated with extracutaneous manifestations, including internal malignancies; therefore, most require a multidisciplinary management approach with a medical geneticist. Finally, dermatologists play a critical role in the diagnosis and management of these conditions, because cutaneous findings are often the presenting manifestations of disease.
Copyright © 2015 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bloom syndrome; Gorlin syndrome; Muir–Torre syndrome; Rothmund–Thomson syndrome; Werner syndrome; dyskeratosis congenita; genetic testing; nonmelanoma skin cancer; oculocutaneous albinism

Mesh:

Year:  2016        PMID: 26892653     DOI: 10.1016/j.jaad.2015.08.073

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  5 in total

Review 1.  Genetic and environmental factors underlying keratinocyte carcinoma risk.

Authors:  Hélène Choquet; Sepideh Ashrafzadeh; Yuhree Kim; Maryam M Asgari; Eric Jorgenson
Journal:  JCI Insight       Date:  2020-05-21

2.  Expanding phenotype of hereditary fibrosing poikiloderma with tendon contractures, myopathy, and pulmonary fibrosis caused by FAM111B mutations: Report of an additional family raising the question of cancer predisposition and a short review of early-onset poikiloderma.

Authors:  Raphaëlle Goussot; Megana Prasad; Corinne Stoetzel; Cédric Lenormand; Hélène Dollfus; Dan Lipsker
Journal:  JAAD Case Rep       Date:  2017-03-19

3.  Characterisation of resistance mechanisms developed by basal cell carcinoma cells in response to repeated cycles of Photodynamic Therapy.

Authors:  Silvia Rocio Lucena; Alicia Zamarrón; Elisa Carrasco; Miguel Angel Marigil; Marta Mascaraque; Montserrat Fernández-Guarino; Yolanda Gilaberte; Salvador González; Angeles Juarranz
Journal:  Sci Rep       Date:  2019-03-18       Impact factor: 4.379

Review 4.  Immunotherapy for the Treatment of Squamous Cell Carcinoma: Potential Benefits and Challenges.

Authors:  Tuba M Ansary; M D Razib Hossain; Mayumi Komine; Mamitaro Ohtsuki
Journal:  Int J Mol Sci       Date:  2022-08-01       Impact factor: 6.208

Review 5.  Basal Cell Carcinoma: A Comprehensive Review.

Authors:  Emi Dika; Federica Scarfì; Manuela Ferracin; Elisabetta Broseghini; Emanuela Marcelli; Barbara Bortolani; Elena Campione; Mattia Riefolo; Costantino Ricci; Martina Lambertini
Journal:  Int J Mol Sci       Date:  2020-08-04       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.